bay x 1005 has been researched along with methacholine chloride in 1 studies
| Studies (bay x 1005) | Trials (bay x 1005) | Recent Studies (post-2010) (bay x 1005) | Studies (methacholine chloride) | Trials (methacholine chloride) | Recent Studies (post-2010) (methacholine chloride) |
|---|---|---|---|---|---|
| 58 | 6 | 8 | 5,443 | 835 | 824 |
| Protein | Taxonomy | bay x 1005 (IC50) | methacholine chloride (IC50) |
|---|---|---|---|
| galanin receptor type 3 | Homo sapiens (human) | 7.365 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamilton, AL; O'Byrne, PM; Watson, RM; Wyile, G | 1 |
1 trial(s) available for bay x 1005 and methacholine chloride
| Article | Year |
|---|---|
Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
Topics: Adult; Area Under Curve; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lipoxygenase Inhibitors; Male; Methacholine Chloride; Quinolines | 1997 |